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Essential hypertension (EH) is a complex disorder that results from the interaction of a number of susceptibility
genes and environmental factors. We studied an isolated Sardinian village (Talana) in which the prevalence of
hypertension is comparable to that in most Western populations. Talana exhibits features, such as slow demographic
growth, high inbreeding, a low number of founders, stable lifestyle and culture, and accurate genealogical records,
that make it suitable for the study of complex disorders. Clinical assessment of the entire adult population (Np
) identified ∼100 hypertensive subjects. For our study, we selected the individuals with the most-severe EH∼ 1,000
(i.e., diastolic blood pressure 1100 mm Hg), belonging to a single deep-rooted pedigree (12 generations), whose
common ancestors lived in the 17th century. We performed a three-stage genomewide search using 36 affected
individuals, by means of parametric linkage and allele-sharing approaches. LOD scores 11 were observed on
chromosomes 1, 2, 13, 15, 17, and 19 (stage I). The most striking result was found in a 7.57-cM region on
chromosome 2p24-p25. All five nonparametric linkage statistics estimated by the SimWalk2 program lie above the
significance threshold of for the whole region. Similar significance was obtained for 2p24-25 when para-P ! .008
metric linkage (LOD score 1.99) and linkage disequilibrium mapping ( ) were used, suggesting that aPp .00006
hypertension-susceptibility locus is located between D2S2278 and D2S168. This finding is strengthened by a recent
report of linkage with marker D2S168 in a hypertensive sib-pair sample from China.
Introduction
Essential hypertension (EH) affects about one quarter of
the adult population in industrialized countries and con-
tributes to considerable morbidity and mortality from
stroke, heart failure, coronary heart disease, and renal
failure (Burt et al. 1995; Vasan et al. 2001; Family Blood
Pressure Program Investigators 2002). EH is a complex
disorder that results from the interaction of a number
of susceptibility genes and environmental factors. Data
from animal models and human population studies sug-
gest that inherited genetic factors influence ∼50% of the
variation in blood pressure (BP) level, but the number
of contributing genes and their relative risks remain un-
known (Kato et al. 1999, 2000; Wright et al. 1999b;
Stoll et al. 2000; Sugiyama et al. 2001).
Three approaches have been employed to identify
genes influencing hypertension: a search for genes show-
Received April 29, 2002; accepted for publication July 10, 2002;
electronically published September 12, 2002.
Address for correspondence and reprints: Dr. AndreaAngius, Istituto
di Genetica delle Popolazioni, Consiglio Nazionale delle Ricerche, Ca-
sella Postale, 07040 S. Maria La Palma, Sassari, Italy. E-mail: angius@
igm.ss.cnr.it
 2002 by The American Society of Human Genetics. All rights reserved.
0002-9297/2002/7104-0017$15.00
ing Mendelian inheritance, candidate-gene evaluation,
and genomewide scans (Timberlake et al. 2001). The
investigation of Mendelian disorders affecting BP has
led to the identification of several genes (Lifton et al.
1992; Shimkets et al. 1994; Hansson et al. 1995; Mune
et al. 1995; Simon et al. 1997; Disse-Nicodeme et al.
2000), but the contribution of these rare conditions to
BP variation in the general population is very small. In
recent years, a growing list of 1100 candidate genes has
been proposed to influence BP, and evidence of linkage
with hypertension has been reported for several of these
(Jeunemaitre et al. 1992; Svetkey et al. 1997; Krushkal
et al. 1998; O’Donnell et al. 1998; Kainulainen et al.
1999). However, none of these candidate genes has been
shown to contribute substantially to BP variability in
the general population. Genomewide scans can be used
to identify chromosomal regions with unknown genes
influencing BP (Hsueh et al. 2000; Levy et al. 2000;
Pankow et al. 2000; Perola et al. 2000; Rice et al. 2000;
Allayee et al. 2001; Hollenberg 2001; Zhu et al. 2001).
Recently, many investigators have recommended the
study of founder populations for complex-trait mapping,
with the expectation that fewer susceptibility genes will
be segregating in a restricted gene pool (Terwilliger and
Weiss 1998; Kruglyak 1999; Wright et al. 1999a; Pel-
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Table 1
Clinical Characteristics of the Study Population
POPULATION
MEAN  SD
% WITH
TREATMENTa
LIFETIME
HISTORY
OF
SMOKING
DBP
(mm Hg)
SBP
(mm Hg)
Age at
Examination
(years)
Height
(cm)
Weight
(kg)
BMI
(kg/m2)
Affected:
Men ( )np 12 96.67  8.8 161.67  12.67 61.58  20.06 163.25  6.45 73.58  11.20 27.58  3.78 50 No
Women ( )np 23 93.96  10.34 162.39  16.51 64.96  8.91 151.00  6.46 63.13  10.04 27.70  4.10 79 No
Combined ( )np 35 94.89  9.82 162.14  15.11 63.80  13.57 155.20  8.68 66.71  11.45 27.66  3.94 69 No
Unaffected:
Men ( )np 19 80.83  6.51 145.83  18.87 64.00  19.77 162.71  5.09 71.64  8.42 26.96  2.01 … …
Women ( )np 23 83.61  8.61 139.35  19.15 57.61  21.64 151.75  3.24 69.18  17.65 30.11  7.88 … …
Combined ( )np 42 82.45  7.97 142.00  19.51 60.81  20.68 157.58  7.01 64.41  10.58 25.80  2.84 … …
Talana ( )np 772 81.87  33.11 137.62  19.03 47.50  20.92 155.06  8.55 63.64  14.09 26.35  4.93 … …
a Proportion taking antihypertensive medications for 1 year.
tonen et al. 2000; Shifman and Darvasi 2001). The ma-
jority of these populations are inbred, and, in some cases,
accurate pedigree information is available, which allows
the analysis of large extended pedigrees. These commu-
nities derive from a small number of founders, and a high
rate of endogamous and consanguineous marriages may
reduce the number of susceptibility genes and increase
genetic homogeneity (Peltonen et al. 2000; Angius et al.
2001). Furthermore, since individuals are exposed to a
common environment and a relatively uniform lifestyle,
nongenetic variability is minimized, and the noise caused
by other etiological determinants is therefore reduced.
We studied an isolated Sardinian village (Talana) in
which the prevalence of hypertension is ∼10% in the
adult population, which is comparable to manyWestern
populations. We performed a multistep genomewide
search (GWS), selecting 35 related individuals with EH
from a deep-rooted pedigree. Sample selection was op-
timized on the basis of the genealogical distance be-
tween individuals and their position in the extended
family. The strategy was based on a search for genomic
segments shared identical-by-descent (IBD) by affected
individuals originating from a common ancestor (Hou-
wen et al. 1994; Nikali et al. 1995; Hovatta et al. 1999).
Subjects and Methods
Population and Genealogical Data
We studied an isolated village, Talana, in central Sar-
dinia, with a population of ∼1,200 inhabitants, char-
acterized by slow population growth, high endogamy,
and high inbreeding. Characterization of maternal and
paternal lines allowed us to establish that 80% of the
present-day population is descended from 8 paternal and
11 maternal ancestral lineages (Angius et al. 2001). Geo-
graphical and cultural isolation have generated a great
deal of homogeneity in lifestyle and eating habits, pro-
viding a uniform environmental and genetic context for
studies of complex diseases. Precise records of births,
deaths, marriages, and people’s origins have been reg-
istered since 1640 in the parochial Quinque Libri and
in the municipal archives. All data were transferred into
appropriate databases, allowing the creation of genea-
logical trees for any individual in the village.
Study Subjects
After an accurate check of BP in ∼1,000 adults (three
BP measures were averaged to derive diastolic BP [DBP]
and systolic BP [SBP]), we identified 100 hypertensive
subjects. BP was measured in the seated position after
10 min of rest, through use of a mercury sphygmoma-
nometer by experienced and certified examiners. A de-
tailed questionnaire was filled out, and a physical ex-
amination was performed. Blood samples were drawn
from all subjects, for serological and biochemical assays
and for DNA extraction. Affection status was estab-
lished on the basis of the following severe criteria: (i) an
SBP150mmHg and/or DBP95mmHg if the patient
was out of therapy or taking one antihypertensive med-
ication, or an SBP 145 mm Hg and/or DBP 90 mm
Hg if the patient was currently taking two or more an-
tihypertensive medications for at least one year; (ii) onset
of hypertension before age 60 years; and (iii) an accurate
anamnesis, as well as the evaluation of renal and hepatic
functionality, plasmatic electrolytes, lipid profile, and
hemocrome, to exclude secondary forms of hyperten-
sion. Exclusion criteria included the use of other drugs,
such as cortisone-based medications or symphaticoton-
ics; the use (by women) of estroprogestinic hormones;
and the presence of nephrolithiasys, vascular diseases,
and diabetes. All individuals participating in the study
signed informed consent forms, and all samples were
taken in accordance with the Declaration of Helsinki
(World Medical Association Web site).
Within the EH-affected group, we selected 35 of the
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individuals with the most-severe EH, of whom 69%
were undergoing treatment and the remainder showed
a DPB 1100 mm Hg, with a mean age at onset of
years and no lifetime history of smoking (ta-54.5 7.8
ble 1). All 35 selected individuals belong to a single deep-
rooted 12-generation pedigree whose founding ancestors
lived in the 17th century (fig. 1).
Genotyping
Genomic DNA was extracted from 7 ml of EDTA-
treated blood, as described by Ciulla et al. (1988). Mul-
tiplex fluorescent–based genotyping was performed us-
ing ABI PRISM linkage mapping set, version 2 (Perkin
Elmer). PCR was performed according to standard pro-
tocols. Microsatellite products were loaded on an ABI
PRISM 3100 DNA Analyzer (PE Biosystems), and data
were processed by GENESCAN version 3.1 and GE-
NOTYPER version 2.5 software. Additional markers in
stage II and stage III were selected from The Genome
Database.
Multistep GWS
Stage I.—In the first stage, we selected only 16 affected
individuals and their close relatives (33 total genotyped
samples), belonging to the pedigree referred to above.
The individuals analyzed in stage I are indicated by ar-
rows in figure 1. Because of computational constraints,
the full family was analyzed by breaking it into four
smaller branches. Four hundred polymorphic microsat-
ellite markers, at an average intermarker distance of ∼10
cM, were used for genotyping. Genetic maps were de-
rived from the Marshfield map (Center for Medical Ge-
netics Web site), and allele frequencies were calculated
using 25 unrelated individuals from the same village. All
pedigree branches were analyzed using both parametric
linkage and nonparametric IBD-sharing approaches.
Regions yielding suggestive or nominal evidence for both
parametric linkage (LOD score 11) and nonparametric
allele sharing ( ) were followed up in the II stage.P ! .05
As suggested by Lander and Kruglyak (1995), the P !
level was considered statistically significant, a P.0001
value of .0001–.01 was considered suggestive, and a P
value of .01–.05 was considered nominal evidence for
linkage.
Stage II.—In this stage, we investigated potentially in-
teresting regions from the stage I screening. We geno-
typed 35 distantly related affected subjects and their
close relatives (77 total genotyped samples) for all mark-
ers showing a positive signal in stage I and for additional
microsatellite markers at an average intermarker dis-
tance of 2 cM. The sample included all 33 individuals
already examined in stage I (fig. 1). In the selection of
additional markers, we chose those with the highest het-
erozygosity. Allele frequencies were estimated by geno-
typing 25 healthy unrelated individuals from the same
village and from the pedigree, which included all affected
and unaffected individuals, to check the accuracy of
results.
Stage III: Linkage disequilibrium (LD) mapping.—The
genomic region spanning 17.57 cM located on 2p24-
p25 was analyzed in detail, adding 10 supplementary
markers: D2S2164, D2S2207, D2S2326, D2S423,
D2S2278, D2S328, D2S2200, D2S262, D2S2199, and
D2S131. The average distance between all analyzed
markers on 2p24-25 is ∼0.97 cM.
Statistical Analyses
GWS data were analyzed using two statistical ap-
proaches: a model-dependent method of linkage analysis
and a nonparametric method to compute allele-sharing
statistics. Two-point LOD scores were calculated by
FASTLINK version 4.1P (Cottingham et al. 1993; Schaf-
fer et al. 1994) in an affected-only strategy, under the
assumption that all unaffected individuals are pheno-
typically unknown, since unaffected subjects do not pro-
vide reliable information on the underlying disease-locus
genotype for a complex disease. Dominant and recessive
models were examined under the assumption of disease
allele frequencies (D) of 0.01 for the dominant model
and 0.1 for the recessive model. A reduced penetrance
of 50% was assumed. Although the choice of genetic
model is arbitrary and, presumably, incorrect, the LOD-
score method can still be robust when a small number
of different models are assumed (Hodge et al. 1997;
Greenberg et al. 1998; Durner et al. 1999). For linkage
analysis, it was necessary to break the entire pedigree
down into four smaller branches. Pedigree size is a severe
limitation for multipoint statistics, where IBD-sharing
analysis is usually restricted to pedigrees of moderate
size and structure. To take advantage of the power pro-
vided by our complex and deep-rooted pedigree struc-
ture, the SimWalk2 program was utilized. This program
is based on Markov chain–Monte Carlo sampling and
simulated annealing algorithms, and it performs multi-
point analyses in a reasonable length of time (Sobel and
Lange 1996). SimWalk2 reports five nonparametric sta-
tistics and their empirical P values, which measure the
degree of clustering (and its significance), among the
affected individuals, of marker alleles originating from
the pedigree founders. All the marker information was
used in this multipoint computation of allele-sharing sta-
tistics. In addition, D statistics were selected over other
nonparametric statistics calculated by SimWalk2, be-
cause they are generally more powerful when the model
of inheritance is unknown. The D statistic is a general
statistic indicating whether a few founder alleles are ov-
errepresented among the affected individuals, and it rep-
resents the extent of allele sharing among all affected
pairs, as measured by their IBD kinship coefficient.
The SimWalk2 program was used for haplotype anal-
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ysis to estimate the most likely set of fully typed maternal
and paternal haplotypes ofmarker loci for each individual
in the pedigree. The program runs over the data several
times, to find the optimal haplotype configuration.
The degree of relationship and the level of clustering
between affected individuals were evaluated by counting
meiotic steps and estimating kinship coefficients (w). The
mean value of indicates that, on average, thewp .04
relatedness of affected individuals within the full ped-
igree is less than that of first cousins (wp 1/16p
). The lack of dense clustering ( ) indicates.0625 wp .04
that splitting the full pedigree into smaller branches
would maximize the power of the linkage analysis, since
extensive amounts of information on segregation and
allele sharing are gained by using small pedigrees that
include related affected individuals, so as to obtain a
higher clustering of affected individuals (i.e., a higher w
value).
An LD mapping statistic test, ancestral haplotype re-
construction (AHR), which is designed to find LD via
haplotype analysis in samples drawn from population
isolates, was also applied (Service et al. 1999). AHR
compares the distribution of haplotypes in affected in-
dividuals with the distribution expected for individuals
bearing a disease mutation descended from a common
ancestor. This test was applied using windows spanning
three markers. Three main parameters are estimated un-
der the null hypothesis: the time since a common founder
(g); the percentage of chromosomes, in affected individ-
uals, that have descended from this founder (a); and the
position (x) of the disease locus. The assumption of link-
age equilibrium under the null-hypothesis likelihood can
be problematic for dense marker spacings (e.g., !1 cM)
and/or for very young populations, because of the po-
tential for “background” LD (BLD) between mark-
ers—that is, LD unrelated to a disease phenotype. When
strong BLD exists in the absence of a disease locus, it
may produce false-positive results (Service et al. 1999).
Because of the strong and extended LD that we observed
in the Talana population (Angius et al. 2001), we tried
to overcome this problem through use of a modified
version of the AHR program that includes LD between
markers under the null hypothesis (McPeek and Strahs
1999; Escamilla et al. 2001).
Exact power estimation and assessment of genome-
wide significance through simulation is impractical for
the whole pedigree, given the complexity of the gene-
alogical structure. Therefore, we estimated the prob-
ability of obtaining specific LOD score values through
simulation of the four smaller branches. Using the av-
erage marker heterozygosity (∼0.70) estimated from
the 400–microsatellite marker set used in the genome-
wide search, we generated 1,000 replicates of the family
data, assuming no linkage under the dominant model,
using the SLINK program (Weeks et al. 1990). For all
replicates, we then calculated the number of times that
the LOD scores exceeded a specific threshold under the
null hypothesis.
Allele Frequency Estimates
In a large pedigree such as the one presented here, it is
important to estimate accurate allele frequencies for link-
age analysis (Boehnke 1991; Ott 1992; Freimer et al.
1993; Nechiporuk et al. 1993; Lindholm et al. 2001). To
check the accuracy of the LOD score results, two sets of
Talana control allele frequencies were used. The PED-
MANAGER program, version 0.9 was utilized to cal-
culate allele frequencies and to check Mendelian incon-
sistencies in the pedigree data. The first set of allele
frequencies was obtained from 25 unrelated individuals
from the village. This was done because a control sample
from an outbred population would not allow a reliable
estimate of common alleles frequencies for Talana.
The second set of allele frequencies was derived from
the genotyped pedigree, including all affected and unaf-
fected individuals (77 genotyped individuals); this group
is biased toward false-negative results, because it includes
a large number (i.e., 35) of affected individuals.
In some cases, allele frequency estimates were signif-
icantly different when evaluated in the two samples (i.e.,
unrelated individuals versus within those within the ped-
igree). However, the second set of allele frequencies was
used to check only its effect on LOD scores.
For some of the additional microsatellite markers used
in stage II, allele frequencies were derived from the entire
Talana population.
Results
Stage I
The stage I genome scan results are given in table 2,
which indicates markers showing evidence of suggestive
linkage to hypertension (LOD score 11, nominal
). Among the 13 identified regions, six loci areP ! .05
particularly interesting, because similar results were ob-
tained using both two-point parametric linkage and mul-
tipoint nonparametric statistics. These six loci were lo-
cated on chromosomes 1, 2, 13, 15, 17, and 19. A
significant nonparametric result (nominal ) wasPp .005
obtained for markers on 2p24-25 and was also confirmed
by two-point parametric linkage, under both the domi-
nant (LOD score 1.46) and the recessive (LOD score 1.53)
models. The regions identified in stage I were further eval-
uated with additional microsatellite markers spaced at an
average distance of ∼2 cM, in all stage I individuals and
in additional affected and control members of the same
extended family.
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Table 2
Results from Stage I
CHROMOSOME MARKER REGION
INTERVAL
(cM)
PEAK
MARKER
ALLELE-
SHARING
P VALUEa
TWO-POINT
LOD SCORE
Dominant
Model
Recessive
Model
1 D1S214–D1S450 9.4–15.9 D1S450 .0402
1 D1S484 NS 1.18 1.68
2 D2S2211–D2S168 9.2–21.7 D2S162 .0050 1.46 1.53
3 D3S1277 NS 1.10
8 D8S270–D8S1784 99.9–110.9 D8S1784 .0407
9 D9S171 NS 1.90 1.65
10 D10S192 .0407
11 D11S901 .0379
12 D12S364 .0389
13 D13S156–D13S173 48.9–88.2 D13S265 .0398
13 D13S173 NS 1.78 2.23
15 D15S153–D15S205 69.2–78.6 D15S205 .0398 1.67 2.21
17 D17S849–D17S831 0–6.0 D17S849 .0631
17 D17S938 NS 1.46 2.10
18 D18S464–D18S53 30.9–39.9 D18S53 .0417
19 D19S414–D19S220 41.8–49.7 D19S220 .0398
19 D19S414 NS 3.10 3.1
a Allele-sharing statistics obtained using SIMWALK2 (Sobel and Lange 1996). NS p not significant
( ).P 1 .05
Stage II
The results of the stage II linkage analysis are shown
in table 3. Most of the stage I results were not confirmed
in the second stage. Following Lindholm et al. (2001),
we used two different sets of allele frequencies for the
calculations, to evaluate how allele frequencies affect
linkage evidence.
Positive stage I linkage results on chromosomes 15
and 17 were not supported by nonparametric statistical
results (table 3). The multipoint allele-sharing results for
chromosomes 15 and 17 were not significant (nominal
). Results showing suggestive linkage to chro-P 1 .05
mosome 1 were supported by nonparametric statistical
results (nominal for D1S450, and nominalPp .0459
for D1S2841), but two-point LOD scoresPp .0137
under the recessive model are !1. On chromosome 13,
the initial linkage findings for marker D13S173 were
not confirmed (table 2), but interesting results were ob-
tained by parametric analysis with marker D13S1306
(LOD scores of 1.90 and 1.95, for the dominant and
recessive models, respectively, under the affected-only
method). The D13S1306 marker was added in stage II
and shows a suggestive LOD score when allele frequen-
cies both from control subjects and from the pedigree
are used, as well as a P value of .0631, which is close
to significance (table 3), from nonparametric analysis.
On chromosome 2, two-point LOD scores of 1.86
(dominant model) and 1.52 (recessive model) were ob-
served in stage I and, using allele frequencies estimated
from the pedigree, we confirmed these results in stage II
(LOD scores of 2.08 and 1.63, under the dominant and
the recessive model, respectively; table 3). In this genomic
region, the interval D2S162–D2S149, which spans ∼13.9
cM, showed strong evidence of linkage (nominal Pp
) when nonparametric statistics were used, indicat-.0047
ing clustering of founder alleles among the affected in-
dividuals (Sobel and Lange 1996). Additional markers,
with an average marker density of ∼0.97 cM (21 markers
analyzed), were used to verify the results on chromosome
2. Figure 2 shows the results of all SimWalk2 nonpara-
metric statistical tests for stage II. All five statistics lie
above the significance threshold of in the 7.57-P ! .008
cM region from D2S162 and D2S1400 and, in particular,
the D statistic is above the significance threshold of P !
from D2S162 and D2S1400, with the maximum.0009
value on D2S423 ( ) (fig. 2). Within this region,Pp .0004
the most interesting linkage result was observed for
marker D2S2278 (LOD score 1.99 under the dominant
model, and LOD score 1.5 under the recessive model).
These linkage scores were not influenced by allele fre-
quency estimates within the pedigree.
To evaluate possible genetic heterogeneity within the
different branches of the pedigree, D statistics were ex-
amined for each branch through use of markers from
the 2p24-p25 region. As shown in figure 3, not all
branches are equally informative for multipoint analysis.
Branch 3 is completely uninformative, whereas branches
1 and 4 show similar significance levels, with a maximum
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Table 3
Results from Stage II
CHROMOSOME MARKER REGION
INTERVAL
(cM)
PEAK
MARKER
ALLELE-
SHARING
P VALUEa
TWO-POINT LOD SCORES
FOR ALLELE FREQUENCIES FROM
Control Population Pedigree
Dominant
Model
Recessive
Model
Dominant
Model
Recessive
Model
1 D1S214–D1S 450 0–6.6 D1S450 .0459 1.59 1.11 NS NS
1 D1S1655–D1S1551 97.6–109.8 D1S2841 .0137 1.60 .97 NS NS
2 D2S162–D2S149 9.1–23.0 D2S287 .0047 1.86 1.52 2.08 1.63
13 … … D13S1306 .0631 1.90 1.95 1.99 2.07
13 … … D13S173 NS 1.31 1.23 NS NS
15 … … D15S205 NS 3.13 3.26 NS NS
17 D17S831–D17S1298 5.9–10.1 D17S938 NS 2.32 2.59 NS NS
NOTE.—NS p not significant ( ).P 1 .05
a Allele sharing statistics obtained with SIMWALK2 (Sobel and Lange 1996).
between D2S162 and D2S168 (fig. 3). The graph of
branch 2 shows its maximum between D2S297 and
D2S1400, with a partial overlap with branches 1 and 4.
We also estimated the probability of obtaining specific
LOD score values through simulation of the four smaller
branches. A LOD score 2 was observed in 13.7% of
the replicates obtained under no linkage, with a 95%
CI of 13.23%–14.30%. A LOD score 3 was observed
in 4.24% of the replicates obtained under no linkage,
with a 95% CI of 3.92%–4.56%.
Although the empirical P value estimated from sim-
ulation of obtaining a LOD score of 2 is not significant
( ), the concordance with results obtained usingPp .14
nonparametric linkage analyses ( ) supports theP ! .0009
evidence for the region being on 2p24-p25. Furthermore,
in the simulation, a specific genetic model for the trait
has to be assumed, and the empirical P value estimates
are valid only under that specific model. Therefore, the
results of the simulation should be judged cautiously.
Stage III: LD Mapping
Haplotypes were estimated using the SimWalk2 pro-
gram. These haplotypes were analyzed using the AHR
program in three overlapping windows of three markers.
The AHR results for the 21 markers are shown in table
4. These data suggest a possible disease locus at D2S2207
(peak LOD score 2.76, equivalent to ) andPp .00174
between D2S2278 and D2S168 (peak LOD score 4.21,
equivalent to ). Marker D2S168 gave a peakPp .00006
LOD score of 3.02, equivalent to a P value of .00095.
This localization between D2S2278 and D2S168 is
strongly supported by allele-sharing and parametric link-
age results (fig. 2; table 3).
Discussion
We report the results of a three-stage linkage study that
aimed to localize susceptibility genes for EH in a genetic
isolate, the Talana population. We studied a large 12-
generation pedigree comprising 35 EH-affected individ-
uals, through use of different approaches. Parametric link-
age analysis can be very powerful for study of the Talana
village, because affected individuals all belong to a ge-
netically isolated population and common ancestors can
be unambiguously identified (Angius et al. 2001; Ombra
et al. 2001). Large pedigrees that include distantly related
affected individuals provide power for allele-sharing de-
tection, since the prior probability of sharing any genome
segment is small for distant relatives, and evidence of IBD
sharing indicates the presence of a genetic factor contrib-
uting to the trait (Houwen et al. 1994; Nikali et al. 1995;
Hovatta et al. 1999). On the basis of their genealogical
distance and position in the Talana hypertension kindred,
a subset of affected individuals sharing common ancestors
were carefully selected for a multistep GWS. The number
of samples required for the initial GWS was optimized by
initially selecting only 16 affected individuals and their
close relatives (33 in total), and a 400–microsatellite
marker scan was performed (stage I). The approach is
based on an economic selection of samples, which takes
advantage of the power provided by pedigree structure
and the reduced genetic heterogeneity resulting from high
inbreeding.
In stage II, selected genomic regions were investigated
further by genotyping an expanded sample of 77 sub-
jects, adding additional microsatellite markers to the
selected regions at ∼2-cM intervals. To evaluate how
allele frequencies affect the linkage results, two different
sets of allele frequencies were used in stage II for the
calculations, either from 25 unrelated individuals from
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Figure 2 Nonparametric statistics estimated by SimWalk2 (Sobel and Lange 1996). Statistic A is the number of different founder alleles
contributing alleles to the affected individuals. Statistic B is the maximum number of alleles among the affected individuals descended from
any one founder allele. Statistic C is the “entropy” of the marker alleles among the affected individuals. Statistic D is the extent of allele sharing
among all affected pairs, as measured by their IBD kinship coefficient. Statistic E is the “NPL_all” statistic, as implemented in GeneHunter.
Talana village or from the entire pedigree, including all
affected and unaffected individuals. The second set of
allele frequencies was used to check only its effect on
LOD scores. For some additional microsatellite markers
used in stage II, the allele frequencies were derived from
the entire Talana population.
In stage I, significant results were obtained for loci
on chromosomes 1, 2, 13, 15, 17, and 19, with the most
striking results on chromosome 2, with a nonparametric
nominal P value of .0050. In stage II, linkage to genomic
regions on chromosomes 1, 2, 13, 15, and 17 was fur-
ther supported by parametric analysis, although, when
allele frequencies were estimated within the pedigree,
the LOD scores decreased on chromosomes 1, 15, and
17. This highlights the importance of using accurate
estimates of allele frequencies in the analysis of extended
pedigrees (Lindholm et al. 2001).
The most striking result was obtained in a 7.57-cM
region on chromosome 2p24-p25. All five nonparametric
statistics estimated by SimWalk2 lie above the signifi-
cance threshold of in the whole region betweenP ! .008
D2S162 and D2S1400 and, in particular, the D statistic
settles above the significance threshold of , withP ! .0009
its maximum value on D2S423 ( ). The resultPp .0004
on chromosome 2p24-p25 is not inflated by the set of
allele frequencies used for initial computations. When
evidence from haplotypes is included, affected individuals
show only small shared haplotypes that segregate with
the disease in pedigree branches (data not shown). It was
not possible to identify one haplotype shared between all
affected individuals. One possible explanation lies in hap-
lotype heterogeneity within the pedigree, which is prob-
ably due to the extended kindred. To evaluate hetero-
geneity within the pedigree, theD-statistic results for each
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Figure 3 Statistic D results for each analyzed branch of the pedigree in the whole region shown in figure 2
analyzed branchwere examined formarkers in the region
2p24-p25. We chose the D statistic over other nonpar-
ametric statistics calculated by SimWalk2 because it is
generally more powerful when the mode of inheritance
is unknown (Weeks and Lange 1988; Garner et al. 2001).
Not all branches were equally informative for allele-shar-
ing analysis. Branch 3 is completely uninformative, but
statistics for branches 1, 2, and 4 lie above the significance
level of between D2S297 and D2S168. TheP ! .015
overlap of the D statistics between branches 1, 2, and
4 indicates a clustering of the founder alleles among
distantly related affected individuals. The analysis of
nonparametric results from all subpedigrees permitted
the identification of a 7.57-cM genomic region. A more
detailed analysis of the overlap between statistics results
in branches 1, 2, and 4 narrowed the localization to
between markers D2S297and D2S168.
In stage III, proposed susceptibility regions were fur-
ther evaluated by LD mapping, which narrowed the
7.57-cM region further through use of the AHR test
statistic. (Service et al. 1999; Escamilla et al. 2001). The
AHR results suggested a possible hypertension locus
localized between markers D2S2278 and D2S168,
which are 0.54 cM apart. A maximum peak LOD score
of 4.21 (nominal ) was obtained at a re-Pp .00006
combination fraction of 0.004 at marker D2S2278, and
a LOD score of 3.02 (nominal ) was ob-Pp .00095
tained at marker D2S168. AHR analysis also gives an
estimate of the time elapsed (g) since a common founder
for the analyzed data. Although it is possible that a
susceptibility mutation shared by hypertensive pro-
bands predates the genealogical reconstruction (i.e., the
17th century), a g value of 10 generations was obtained
for all markers showing significant linkage results.
The concordance of results on chromosomal region
2p24-p25 obtained using parametric and nonparametric
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Table 4
AHR results from Three-Marker Intervals on Chromosome 2p24-p25
Three-Marker Interval and Genetic Distances
Peak LOD
Score
Location of Peak Score
(Recombination Fraction)a
Estimate
of g
Estimate
of a
D2S1780–4.05 cM–D2S2166–.2 cM–D2S2211 .18 .017680 from D2S1780 1,000 .44
D2S2166–.2 cM–D2S2211–2.27 cM–D2S2952 1.09 .018066 from D2S2211 800 .86
D2S2211–2.27 cM–D2S2952–.54 cM–D2S2164 .48 .004519 from D2S2211 400 .46
D2S2952–.54 cM–D2S2164–1.61 cM–D2S162 1.06 At D2S2164 10 .12
D2S2164–1.61 cM–D2S162–.54 cM–D2S2207 .19 .004301 from D2S162 20 .04
D2S162–.54 cM–D2S2207–.00 cM–D2S2326 2.76 At D2S2207 10 .08
D2S2207–.00 cM–D2S2326–.65 cM–D2S287 1.39 .005173 from D2S2326 10 .08
D2S2326–.65 cM–D2S287–.88 cM–D2S423 2.05 .005173 from D2S2326 10 .08
D2S287–.88 cM–D2S423–1.47 cM–D2S398 1.12 At D2S287 30 .12
D2S423–1.47 cM–D2S398–2.95 cM–D2S297 1.37 .023052 from D2S398 10 .12
D2S398–2.95 cM–D2S297–.00 cM–D2S2278 1.09 .005865 from D2S398 500 .76
D2S297–.00 cM–D2S2278–.54 cM–D2S168 4.21 .004301 from D2S2278 10 .10
D2S2278–.54 cM–D2S168–.54 cM–D2S328 2.67 At D2S2278 10 .08
D2S168–.54 cM–D2S328–.00 cM–D2S2200 3.02 At D2S168 10 .08
D2S328–.00 cM–D2S2200–.00 cM–D2S1400 1.93 .000001 from D2S328 10 .10
D2S2200–.00 cM–D2S1400–.00 cM–D2S262 2.12 .000001 from D2S1400 1,000 .14
D2S1400–.00 cM–D2S262–3.45 cM–D2S2199 .50 At D2S1400 30 .14
D2S262–3.45 cM–D2S2199–.15 cM–D2S131 .58 .006853 from D2S262 300 .56
D2S2199–.15 cM–D2S131–2.84 cM–D2S149 1.61 .022212 from D2S131 10 .14
NOTE.—Study sample consisted of 35 individuals with EH and 42 unaffected individuals.
a Position (x) of the disease locus with the distance (recombination fraction) from the marker.
linkage analyses and LD mapping suggests a hyperten-
sion susceptibility locus located between D2S2278 and
D2S168. This hypothesis is further strengthened by a
recent report by Zhu et al. (2001), who found evidence
for linkage (two-point nonparametric linkage Z score
1.89; ) with marker D2S168 in a GWS of af-Pp .031
fected sib pairs from the Shanghai area. However, they
did not replicate this result in the second stage, through
use of an independent sib-pair sample, despite adding
additional markers close to D2S168. In our study, we
used a denser marker map (∼0.97-cM spacing), thus al-
lowing a better estimate of recombination close to
D2S168. Given the complexity of the inheritance of hy-
pertension and possible phenotype/environment inter-
actions complicating the detection of underlying genetic
factors, the evidence for nonparametric linkage in the
same locus in Italian and Chinese families makes this a
region of interest. No hypertension candidate genes have
previously been reported within or in the vicinity of the
identified locus. In this genomic region, there are seven
predicted genes that apparently are not involved in the
regulation of BP or the development of hypertension.
Further studies are needed to characterize and complete
the sequence, in order to identify other possible candidate
genes.
In the small Talana population, LD has been shown
to span a relatively wide interval on the X chromosome,
suggesting the possibility of using an LD approach to
identify IBD regions associatedwith complex traits, using
a genomewide search at a low marker density (Wright et
al. 1999a; Angius et al. 2001, 2002; Ombra et al. 2001).
When the large amount of information available from
the extended genealogy was used, only 16 individuals
with EH were selected from the pedigree for the initial
GWS for linkage. A small number of genomic regions
showed suggestive evidence of linkage to essential hy-
pertension. Both parametric and nonparametric linkage
approaches identified a region on chromosome 2p24-p25
that may harbor a locus for susceptibility to essential
hypertension. An allele-sharing statistic and LD-based
mapping, as implemented in AHR, proved to be sensitive
methods for detecting a disease locus,whereas parametric
linkage results were affected by different sets of allele
frequencies used for calculations. The results provide sig-
nificant evidence for a susceptibility locus on chromo-
some 2p24-p25, and, although this locus has been iden-
tified in a genetic isolate, it may also play a role in EH
in other populations.
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